Frédérique Penault-Llorca
12PUBLICATIONS
57CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Apr 09, 2026
Identification of ribosomal protein eL21 as a novel externalized protein and a target in triple-negative breast cancer.Lucie Arnould, Nina Radosevic-Robin, Laura Duranton
|Aug 24, 2025
Association Between Daily Timing of Everolimus and Survival in High-Risk HR+/HER2- Early Breast Cancer: A Sub-Analysis of the UCBG-UNIRAD Trial.Enora Laas, Anne-Sophie Hamy, Thomas Bachelot
|Aug 22, 2025
Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay.François-Clément Bidard, Grégoire Gessain, Thomas Bachelot
|Mar 24, 2025
Emerging molecular testing paradigms in non-small cell lung cancer management-current perspectives and recommendations.Frédérique Penault-Llorca, Mark A Socinski
|May 23, 2022
Everolimus Added to Adjuvant Endocrine Therapy in Patients With High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer.Thomas Bachelot, Paul Cottu, Sylvie Chabaud
Pageof 2
Frequent Collaborators
3 joint publications
Jerome Lemonnier
2 joint publications
Fabrice Andre
2 joint publications
Sunil S Badve
2 joint publications
Sylvie Giacchetti
2 joint publications
Anne-Claire Hardy-Bessard
2 joint publications
Thomas Bachelot
1 joint publications
Samuel C Y Leung
1 joint publications
David L Rimm
1 joint publications
Balazs Acs
1 joint publications
Matthew J Ellis
